Getting into the Brain

@article{Patel2009GettingIT,
  title={Getting into the Brain},
  author={Mayur M Patel and B. R. Goyal and Shraddha V. Bhadada and Jay S Bhatt and A. Amin},
  journal={CNS Drugs},
  year={2009},
  volume={23},
  pages={35-58}
}
Being the most delicate organ of the body, the brain is protected against potentially toxic substances by the blood-brain barrier (BBB), which restricts the entry of most pharmaceuticals into the brain. The developmental process for new drugs for the treatment of CNS disorders has not kept pace with progress in molecular neurosciences because most of the new drugs discovered are unable to cross the BBB. The clinical failure of CNS drug delivery may be attributed largely to a lack of appropriate… Expand
Intrathecal delivery of protein therapeutics to the brain: a critical reassessment.
TLDR
Blood-brain barrier functions and cerebrospinal fluid dynamics and their relevance to drug delivery via the intrathecal route are reviewed, and several characteristics of protein therapeutics that can allow them to be successfully delivered intrathecally are outlined. Expand
Nanoscale drug delivery systems and the blood–brain barrier
TLDR
This review comprehensively discusses the functional morphology of the BBB and the challenges that must be overcome by drug-delivery systems and elaborates on the potential targets, mechanisms, and formulations to improve drug delivery to the CNS. Expand
Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.
  • Joana Bicker, G. Alves, A. Fortuna, A. Falcão
  • Computer Science, Medicine
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
  • 2014
TLDR
In vitro models, including non-cell based and cell-based models, and in vivo models are presented, with a particular emphasis on their methodological aspects and their contribution to the improvement of brain drug delivery strategies and drug transport across the blood-brain barrier is discussed. Expand
Evolving new-age strategies to transport therapeutics across the blood-brain-barrier.
TLDR
Insight is provided into the emerging approaches of peptide delivery and the non-invasive and brain-specific molecular Trojan horse targeting technologies and the several challenges in the clinical development of BBB penetrating IgG fusion protein have been discussed. Expand
Nano-enabled delivery systems across the blood–brain barrier
TLDR
The possibility to employ nano-enabled materials for delivery of drug across the blood–brain barrier and the recent advances in nanotechnologies for therapy of the CNS diseases are reviewed. Expand
Key for crossing the BBB with nanoparticles: the rational design
TLDR
Depending on the chosen pathway to cross the BBB, nanoparticle material, size and surface properties such as functionalization and charge should be tailored to fit the specific route of BBB crossing. Expand
In vitro blood brain barrier models as a screening tool for colloidal drug delivery systems and other nanosystems
The brain is one of the least accessible organs of the body due to the presence of the blood-brain barrier (BBB), thus making drug delivery to the brain quite a challenge. Various strategies haveExpand
In vitro screening of nanomedicines through the blood brain barrier: A critical review.
TLDR
An in-depth analysis of the currently available in vitro blood-brain barrier models (both cell-based and non-cell-based) with the focus on their suitability for understanding the biological brain distribution of forthcoming nanomedicines is provided. Expand
The blood-brain barrier in vitro using primary culture: implications for studies of therapeutic gene expression and iron transport
TLDR
In addition to astrocytes, pericytes were found to be a source of ferrooxidase activity within the brain, indicating that both of these cell types could be implicated in the control of iron release from BCECs and further transport into the brain. Expand
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
The blood–brain barrier (BBB) plays a vital role in the protection and maintenance of homeostasis in the brain. In this way, it is an interesting target as an interface for various types of drugExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 226 REFERENCES
Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system.
  • W. Scheld
  • Medicine
  • Reviews of infectious diseases
  • 1989
TLDR
Methods developed for increasing drug delivery to the CNS by circumvention and/or manipulation of the blood-brain barrier have included direct injection into the CSF, administration of prodrugs or chemical delivery systems, or reversible "opening" of the BBB by hyperosmotic agents, pentylenetetrazole, etoposide, DMSO, or other agents. Expand
Nanoparticulate systems for brain delivery of drugs.
TLDR
Intravenously injected doxorubicin-loaded polysorbate 80-coated nanoparticles were able to lead to a 40% cure in rats with intracranially transplanted glioblastomas 101/8, and may be especially helpful for the treatment of the disseminated and very aggressive brain tumors. Expand
New technologies for drug delivery across the blood brain barrier.
The blood-brain barrier (BBB) efficiently restricts penetration of therapeutic agents to the brain from the periphery. Therefore, discovery of new modalities allowing for effective delivery of drugsExpand
The blood-brain barrier: Bottleneck in brain drug development
TLDR
This work has shown that the blood-brain barrier provides the platform for CNS drug delivery programs, which should be developed in parallel with traditional CNS drug discovery efforts in the molecular neurosciences. Expand
New directions in the delivery of drugs and other substances to the central nervous system.
TLDR
Three main approaches have been used in this chapter: modifying the barrier, modifying the agents, and circumventing the barrier in the search for the best method for CNS delivery. Expand
Drug delivery to the central nervous system: a review.
TLDR
This review intends to detail the recent advances in the field of brain-targeting, rational drug design approach and drug delivery to CNS. Expand
Transporting therapeutics across the blood-brain barrier.
TLDR
The properties of this barrier that complicate drug delivery to the brain, and some of the most hopeful strategies for overcoming or bypassing the barrier in humans are reviewed. Expand
Brain drug delivery technologies: novel approaches for transporting therapeutics.
TLDR
An insight is provided into some of the strategies developed to enhance drug delivery across the blood-brain barrier and the current challenge is to develop drug-delivery strategies that will allow the passage of drug molecules through the BBB in a safe and effective manner. Expand
Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
TLDR
The use of nanotechnologies (liposomes, nanoparticles) is especially discussed in the ultimate part of the review evidencing their potentiality as non-invasive technique in the brain delivery of drugs with the possibility to target specific brain tissue thanks to ligand linked to carrier surface. Expand
Potential of solid lipid nanoparticles in brain targeting.
TLDR
The barriers to CNS drug delivery, strategies to bypass the blood-brain barrier and characterization methods of SLNs and their usefulness are discussed. Expand
...
1
2
3
4
5
...